FIELD: biochemistry; biotechnology.
SUBSTANCE: disclosed are a hydrogel precursor composition in the form of an unreacted powder, comprising a thrombin activating enzyme, a transglutaminase cross-linking factor XIII enzyme, structural compounds A or A and B, which are branched polyethylene glycol, each having a functional group; method of producing said composition; kit for producing a hydrogel, comprising a container filled with a hydrogel precursor composition, a container with a reaction buffer, and, if necessary, instructions for a user; method of producing a hydrogel by resuspension of the disclosed composition in a reaction buffer, preferably containing calcium ions.
EFFECT: inventions provide reproducibility of hydrogels obtained from a hydrogel precursor composition and improvement of their consumer properties.
13 cl, 7 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION COMPRISING FACTOR VIIA AND FACTOR XIII | 2001 |
|
RU2272648C2 |
METHOD FOR UTILIZATION OF FIBRIN SEALING MATERIAL, METHOD OF PREPARING COMPOSITION, COMPOSITIONS, AND KITS | 1993 |
|
RU2143924C1 |
PANELS OF DISCRETE MICROENVIRONMENTS OF CELL CULTURES, METHODS FOR MAKING SUCH PANELS AND USE THEREOF | 2014 |
|
RU2718491C2 |
DRY COMPOSITION OF TRANSGLUTAMINE | 2009 |
|
RU2616847C2 |
METHOD OF PRODUCING FIBRINOGEN USING STRONG ANION EXCHANGE RESIN AND FIBRINOGEN-CONTAINING PRODUCT | 2011 |
|
RU2603103C2 |
BIOGEL | 2007 |
|
RU2503464C2 |
COMPLEMENTED MATRIXES FOR TREATING BONE FRACTURES | 2006 |
|
RU2422172C2 |
METHOD FOR CLEANING FIBRINOGEN, FIBRINOGEN PRODUCT AND MEANS FOR CLEANING OR PRODUCING FIBRINOGEN PRODUCT | 2013 |
|
RU2663792C2 |
COMPOSITION WITH BOUND HYALURONIC ACID FOR DEVELOPING TISSUES | 2003 |
|
RU2351367C9 |
FGF-18 COMPOSITION IN ALGINATE/COLLAGEN HYDROGELS | 2014 |
|
RU2698210C2 |
Authors
Dates
2022-04-18—Published
2017-07-20—Filed